Streetbeat News

Earnings

BA

Boeing Company (NYSE:BA) shares rose approximately 3% following the announcement of new contracts with Middle Eastern airlines at the Dubai Airshow. Emirates ordered 90 777X airplanes, increasing their backlog to 205, and added five more 787 jets to their order. flydubai placed an order for 30 787-9 Dreamliners, and Royal Jordanian ordered four 787-9 Dreamliner jets. Boeing's 2023 Commercial Market Outlook anticipates widebody airplanes will represent 45% of Middle East airline deliveries over the next 20 years. Despite a strong quarter in revenue, Boeing's adjusted loss per share was wider than expected.

Portfolio Pulse from Lekha Gupta

November 13, 2023 | 1:35 pm

SCX

L S Starrett (NYSE:SCX) reported a slight decrease in Q1 EPS to $0.25 from $0.27 YoY, while sales saw a marginal increase to $60.64M from $60.46M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:34 pm

INTS

Intensity Therapeutics reported a Q3 EPS loss of $(0.17), missing the $(0.09) estimate by 88.89%. Despite this miss, the loss improved by 67.31% from the $(0.52) per share loss in the same quarter last year. The company has approximately $15.6M in cash, cash equivalents, and marketable securities, which is expected to fund operations into the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:32 pm

KALA

Kala Bio (NASDAQ:KALA) reported Q3 earnings with an EPS of $-3.41, missing estimates by 58.6% compared to the expected $-2.15. Revenue also decreased by $420 thousand from the same period last year. Following last quarter's earnings miss, KALA's share price dropped by 1.6% the next day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:30 pm

ARTL

Artelo Biosciences (NASDAQ:ARTL) reported a Q3 EPS loss of $(0.83), which was below the consensus estimate of $(0.65) by 27.69%. The reported loss represents a slight increase from the $(0.82) per share loss in the same quarter of the previous year. The company also reported having $12.9 million in cash and investments.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:30 pm

AVTE

Aerovate Therapeutics reported Q3 EPS of $(0.71), missing the $(0.69) estimate, a 26.79% decrease from the previous year. They have $135.2M in cash, enough to fund operations into 2026.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:28 pm

ADTN

ERIC

XRX

Three tech stocks with high dividend yields have been rated by Wall Street's most accurate analysts. Xerox Holdings Corporation (XRX) has a 7.49% yield but faces downgrades with a reduced price target. ADTRAN Holdings, Inc. (ADTN) offers a 6.63% yield, with mixed ratings and a lowered price target. Telefonaktiebolaget LM Ericsson (ERIC) provides a 5.47% yield, with a reduced price target and a downgrade to Market Perform. All three companies reported mixed financial results or a decline in sales.

Portfolio Pulse from Lisa Levin

November 13, 2023 | 1:27 pm

AVTE

Aerovate Therapeutics (NASDAQ:AVTE) reported Q3 earnings with an EPS of $-0.71, missing estimates by 2.9% and showing no revenue change from the same period last year. The company's past earnings miss was followed by a 1.14% share price drop the next day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:25 pm

ARTL

Artelo Biosciences (NASDAQ:ARTL) reported Q3 earnings with an EPS of $-0.83, missing estimates by 27.69% compared to the expected $-0.65. Revenue remained unchanged from the same period last year. The previous quarter's earnings beat led to a 2.81% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:25 pm

MNPR

SNES

STNE

StoneCo Ltd. (NASDAQ:STNE) shares increased by over 6% in pre-market trading following the company's third-quarter earnings report, which surpassed market expectations. StoneCo reported adjusted earnings of 27 cents per share against the estimated 22 cents, with sales of $643.35 million exceeding the forecast of $610.17 million. Other stocks also showed pre-market movements, with notable gainers including SenesTech, Inc. (NASDAQ:SNES), Collective Audience, Inc. (NASDAQ:CAUD), and Tivic Health Systems, Inc. (NASDAQ:TIVC), among others. Conversely, several stocks were trading lower, such as Monopar Therapeutics (NASDAQ:MNPR), eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), and Motus GI Holdings, Inc. (NASDAQ:MOTS).

Portfolio Pulse from Lisa Levin

November 13, 2023 | 1:24 pm